Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference
31.01.2024 - WALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) - Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced ...
Source: wallstreet-online.de